Clinical Trial Update: Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating adjunctive acetylsalicylic acid and ibuprofen for pulmonary and MDR tuberculosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis
• Tuberculosis Mdr

Drugs mentioned

• Acetylsalicylic acid (Aspirin)
• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Fundació Institut Germans Trias i Pujol | Conditions: Tuberculosis, Pulmonary, Tuberculosis, MDR | Phase 2 | Status: UNKNOWN